Asprin Dosing Estimator in Healthy Adults

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

October 30, 2021

Study Completion Date

October 30, 2021

Conditions
Aspirin Sensitivity
Interventions
DRUG

Aspirin

Participants will be categorized into 3 BMI groups and will be randomly given various doses of aspirin to compare effectiveness and create a dosing regimen.

Trial Locations (1)

84112

University of Utah, Salt Lake City

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

lead

University of Utah

OTHER

NCT04040465 - Asprin Dosing Estimator in Healthy Adults | Biotech Hunter | Biotech Hunter